Cohance Lifesciences Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹544.55 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 1.98 per cent from ₹555.57 crore. This corresponds to a year-on-year *(YoY) decline of 19.47 per cent.
Operating Profit
Operating Profit stands at ₹15.27 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 37.32 per cent from ₹24.36 crore. This corresponds to a year-on-year *(YoY) decline of 52.81 per cent.
PBDT
PBDT stands at ₹58.52 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 4.69 per cent from ₹61.40 crore. This corresponds to a year-on-year *(YoY) decline of 38.17 per cent.
Profit Before Tax
Profit Before Tax stands at ₹40.60 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 51.53 per cent from ₹83.77 crore. This corresponds to a year-on-year *(YoY) decline of 80.15 per cent.
Net Profit
Net Profit stands at ₹41.58 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 43.87 per cent from ₹74.08 crore. This represents a 72.84 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Cohance Lifesciences Ltd News
Cohance Lifesciences Ltd Earnings
- YOY
- QOQ
Cohance Lifesciences Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Cohance Lifesciences Ltd Research Reports
Cohance Lifesciences Ltd Financial Reports
Cohance Lifesciences Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Cohance Life | 6.61% | -6.18% | -21.11% | -43.50% | -64.26% | -71.65% |
| Granules India | 2.30% | 2.19% | 1.39% | 5.06% | 27.37% | 9.43% |
| Rubicon Research | 0.67% | 2.92% | 19.45% | 14.09% | 26.43% | 26.43% |
| Caplin Point Lab | -0.55% | -1.68% | -5.64% | -11.37% | -19.80% | -15.47% |
| Concord Biotech | 0.00% | -6.43% | -12.03% | -20.65% | -30.26% | -31.46% |
| Alivus Life | -0.45% | -2.00% | 3.41% | -0.89% | -6.77% | -11.12% |
| Viyash Scientific | 1.29% | 0.16% | 8.78% | -11.23% | 26.75% | 48.85% |
Company Info
Company Information
Chairman & Exec. Director : Vivek Sharma
Non-Exec & Non-Independent Dir : Vinod Padikkal
Independent Non Exe. Director : K G Ananthakrishnan
Independent Non Exe. Director : Matangi Gowrishankar
Independent Non Exe. Director : Vinod Rao
Independent Non Exe. Director : U B Pravin Rao
Independent Non Exe. Director : Jaishankar Krishnan
Non Executive Director : Pankaj Patwari
Non Executive Director : Shweta Jalan
CS / Compliance Officer / Legal Head : KUNDAN KUMAR JHA
Whole Time Director & Chief Financial Officer : Himanshu Agarwal